InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,558.00
(
-2.23%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.63
(
0.24%
)
Bitcoin
63,998.70
(
0.77%
)
Post# of 197512
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

NYC Trader

Send PM Follow Ignore
Followers 1084
Posts 142881
Boards Moderated 5
Alias Born 01/25/2009

NYC Trader

Re: None

Wednesday, 03/25/2015 9:57:08 AM

Wednesday, March 25, 2015 9:57:08 AM

Post# of 197512
$BICX Highlights

*Increase in recent main stream media exposure - Naltrexone was recently covered in Time Magazine and The New York Times.

*BioCorRx and/or its Start Fresh Program was recently featured on The Doctors, Bloomberg, Fox Business News, and in multiple local news segments in Los Angeles, San Francisco, San Diego, New York and others. Many of those can be seen on the company’s website, Facebook page or YouTube channel.

*“By focusing on branding and expansion to reach mass market adoption, BioCorRx Inc. will continue to position its Start Fresh Program as a leader in treating alcohol and opioid addiction,” stated Lourdes Felix.

*Company became cash flow positive in 2014 for the first time in its history due to increase in license fees, royalties and direct sales.

Visit my board"NY Penny Stock Exchange" for today's pick at http://investorshub.advfn.com/boards/board.aspx?board_id=16752

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up